GENinCode (LON:GENI) Stock Price Down 9.1% – Here’s Why

GENinCode Plc (LON:GENI) dropped 9.1% during mid-day trading on Tuesday . The stock traded as low as GBX 2 ($0.03) and last traded at GBX 2 ($0.03). Approximately 161,645 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 753,114 shares. The stock had previously closed at GBX 2.20 ($0.03).

GENinCode Trading Up 17.4%

The firm’s 50-day moving average price is GBX 1.96 and its 200-day moving average price is GBX 3.01. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28. The company has a market cap of £4.17 million, a P/E ratio of -0.68 and a beta of 0.66.

GENinCode (LON:GENI) last posted its earnings results on Wednesday, June 4th. The company reported GBX (2.53) (($0.03)) earnings per share for the quarter. GENinCode had a negative return on equity of 289.74% and a negative net margin of 228.70%. As a group, equities research analysts expect that GENinCode Plc will post -7.1299999 earnings per share for the current fiscal year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.